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Background
The formation of biofilm on the tooth surface is a result
of the process of colonization of cariogenic bacteria,
especially Streptococcus mutans, the main responsible for
cariogenic (acid production) of dental biofilms [1]. The
removal and chemical control of dental biofilm with
chlorhexidine digluconate 0.12% (CLX) has been the
most effective antimicrobial agent of choice clinic. How-
ever, despite its indisputable efficacy, no side effects such
as darkening of the teeth, tongue and restorations, burn-
ing mouth and changes in taste. The formation of inclu-
sion compounds CLX for the controlled release of the
compound in a lower concentration could be a viable
strategy to reduce these side effects without diminishing
the therapeutic efficacy of the product [2,3]. Against this
background, this study aimed to prepare nanocapsules
CLX (processing aid) (1.2%) in model spray drying using
modified starch as the encapsulating agent, tested in bio-
film model using bovine teeth.
Methods
The microbiological evaluation of in vitro antimicrobial
activity of different formulations was made against
S. mutans strain UA159 grown in artificial saliva, a
model of biofilm produced in the flow cell. The biofilm
on the teeth was exposed to nano-CLX, CLX Periogard
® and standard laboratory for 2 minutes. Cell viability
was measured by fluorescence LiveDeadBactLightTM
Kit with dyes Syto ® 9 and Propidium Iodide.
Results
The results showed equivalence between efficiency and
CLX laboratory Periogard ®, featuring both 0% percen-
tage of S. mutans after treatment. The CLX nanocoated
(1.2%) showed significant efficiency at 90% cell death
indicating controlled release of the drug. The model CLX
nanocoated by spray drying, and modified starch as
encapsulating agents when tested in a model of biofilm
using bovine teeth showed good response when used as
antimicrobial.
Conclusions
The molecular nature of chlorhexidine ensures its effec-
tiveness in combating bacterial biofilms, and such activ-
ity is in fact already enshrined. However, the alternative
formulation nanocapsulada allows an effective control of
its release, ensuring control of the main process cario-
genic bacteria, thereby reducing their undesirable aes-
thetic point of view, representing new alternative for the
application and release of a single antimicrobial without
the immediate need for new drugs.
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